97 related articles for article (PubMed ID: 15845396)
1. Apolipoprotein E activates the low-activity form of human phospholipid transfer protein.
Jänis MT; Metso J; Lankinen H; Strandin T; Olkkonen VM; Rye KA; Jauhiainen M; Ehnholm C
Biochem Biophys Res Commun; 2005 May; 331(1):333-40. PubMed ID: 15845396
[TBL] [Abstract][Full Text] [Related]
2. Reduced CSF PLTP activity in Alzheimer's disease and other neurologic diseases; PLTP induces ApoE secretion in primary human astrocytes in vitro.
Vuletic S; Peskind ER; Marcovina SM; Quinn JF; Cheung MC; Kennedy H; Kaye JA; Jin LW; Albers JJ
J Neurosci Res; 2005 May; 80(3):406-13. PubMed ID: 15795933
[TBL] [Abstract][Full Text] [Related]
3. Influence of Isoforms and Carboxyl-Terminal Truncations on the Capacity of Apolipoprotein E To Associate with and Activate Phospholipid Transfer Protein.
Dafnis I; Metso J; Zannis VI; Jauhiainen M; Chroni A
Biochemistry; 2015 Sep; 54(38):5856-66. PubMed ID: 26337529
[TBL] [Abstract][Full Text] [Related]
4. Phospholipid transfer protein is present in human tear fluid.
Jauhiainen M; Setälä NL; Ehnholm C; Metso J; Tervo TM; Eriksson O; Holopainen JM
Biochemistry; 2005 Jun; 44(22):8111-6. PubMed ID: 15924430
[TBL] [Abstract][Full Text] [Related]
5. Cell-associated and extracellular phospholipid transfer protein in human coronary atherosclerosis.
O'Brien KD; Vuletic S; McDonald TO; Wolfbauer G; Lewis K; Tu AY; Marcovina S; Wight TN; Chait A; Albers JJ
Circulation; 2003 Jul; 108(3):270-4. PubMed ID: 12835223
[TBL] [Abstract][Full Text] [Related]
6. Determination of human plasma phospholipid transfer protein mass and activity.
Jauhiainen M; Ehnholm C
Methods; 2005 Jun; 36(2):97-101. PubMed ID: 15893933
[TBL] [Abstract][Full Text] [Related]
7. Plasma apolipoprotein E concentration is an important determinant of phospholipid transfer protein activity in type 2 diabetes mellitus.
Tan KC; Shiu SW; Wong Y; Wong WK; Tam S
Diabetes Metab Res Rev; 2006; 22(4):307-12. PubMed ID: 16389649
[TBL] [Abstract][Full Text] [Related]
8. Interfacial and lipid transfer properties of human phospholipid transfer protein: implications for the transfer mechanism of phospholipids.
Setälä NL; Holopainen JM; Metso J; Wiedmer SK; Yohannes G; Kinnunen PK; Ehnholm C; Jauhiainen M
Biochemistry; 2007 Feb; 46(5):1312-9. PubMed ID: 17260960
[TBL] [Abstract][Full Text] [Related]
9. Human apoA-I increases macrophage foam cell derived PLTP activity without affecting the PLTP mass.
Robciuc MR; Metso J; Sima A; Ehnholm C; Jauhiainen M
Lipids Health Dis; 2010 Jun; 9():59. PubMed ID: 20534134
[TBL] [Abstract][Full Text] [Related]
10. Macrophage phospholipid transfer protein deficiency and ApoE secretion: impact on mouse plasma cholesterol levels and atherosclerosis.
Liu R; Hojjati MR; Devlin CM; Hansen IH; Jiang XC
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):190-6. PubMed ID: 17038631
[TBL] [Abstract][Full Text] [Related]
11. Cholesterol efflux from macrophage foam cells is enhanced by active phospholipid transfer protein through generation of two types of acceptor particles.
Vikstedt R; Metso J; Hakala J; Olkkonen VM; Ehnholm C; Jauhiainen M
Biochemistry; 2007 Oct; 46(42):11979-86. PubMed ID: 17900150
[TBL] [Abstract][Full Text] [Related]
12. Increased atherosclerotic lesions in apoE mice with plasma phospholipid transfer protein overexpression.
Yang XP; Yan D; Qiao C; Liu RJ; Chen JG; Li J; Schneider M; Lagrost L; Xiao X; Jiang XC
Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1601-7. PubMed ID: 12855484
[TBL] [Abstract][Full Text] [Related]
13. Binding of phospholipid transfer protein (PLTP) to apolipoproteins A-I and A-II: location of a PLTP binding domain in the amino terminal region of apoA-I.
Pussinen PJ; Jauhiainen M; Metso J; Pyle LE; Marcel YL; Fidge NH; Ehnholm C
J Lipid Res; 1998 Jan; 39(1):152-61. PubMed ID: 9469594
[TBL] [Abstract][Full Text] [Related]
14. Active plasma phospholipid transfer protein is associated with apoA-I- but not apoE-containing lipoproteins.
Cheung MC; Albers JJ
J Lipid Res; 2006 Jun; 47(6):1315-21. PubMed ID: 16520487
[TBL] [Abstract][Full Text] [Related]
15. Phospholipid transfer protein in human plasma associates with proteins linked to immunity and inflammation.
Cheung MC; Vaisar T; Han X; Heinecke JW; Albers JJ
Biochemistry; 2010 Aug; 49(34):7314-22. PubMed ID: 20666409
[TBL] [Abstract][Full Text] [Related]
16. Isolation and partial characterization of the inactive and active forms of human plasma phospholipid transfer protein (PLTP).
Kärkkäinen M; Oka T; Olkkonen VM; Metso J; Hattori H; Jauhiainen M; Ehnholm C
J Biol Chem; 2002 May; 277(18):15413-8. PubMed ID: 11854286
[TBL] [Abstract][Full Text] [Related]
17. Remodeling of apolipoprotein E-containing spherical reconstituted high density lipoproteins by phospholipid transfer protein.
Settasatian N; Barter PJ; Rye KA
J Lipid Res; 2008 Jan; 49(1):115-26. PubMed ID: 17921435
[TBL] [Abstract][Full Text] [Related]
18. Atheroprotective potential of macrophage-derived phospholipid transfer protein in low-density lipoprotein receptor-deficient mice is overcome by apolipoprotein AI overexpression.
Valenta DT; Ogier N; Bradshaw G; Black AS; Bonnet DJ; Lagrost L; Curtiss LK; Desrumaux CM
Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1572-8. PubMed ID: 16675720
[TBL] [Abstract][Full Text] [Related]
19. Phospholipid transfer protein (PLTP) causes proteolytic cleavage of apolipoprotein A-I.
Jauhiainen M; Huuskonen J; Baumann M; Metso J; Oka T; Egashira T; Hattori H; Olkkonen VM; Ehnholm C
J Lipid Res; 1999 Apr; 40(4):654-64. PubMed ID: 10191289
[TBL] [Abstract][Full Text] [Related]
20. Haptoglobin binds the antiatherogenic protein apolipoprotein E - impairment of apolipoprotein E stimulation of both lecithin:cholesterol acyltransferase activity and cholesterol uptake by hepatocytes.
Cigliano L; Pugliese CR; Spagnuolo MS; Palumbo R; Abrescia P
FEBS J; 2009 Nov; 276(21):6158-71. PubMed ID: 19758344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
